Eli Lilly and Novo Nordisk are tackling heart health next
In This Story After revolutionizing the weight-loss drug market, Novo Nordisk (NVO-6.13%) and Eli Lilly (LLY-5.60%) are setting their sights on heart health. How Trump’s tariffs could make your iPhone…